Enable Accessibility Enable Accessibility

Quarterly Results FY2022 (April 2022-March 2023)

Earnings announcement for the 3rd quarter FY2022 (to be released on February 2, 2023)

Webcast for Investors, Analysts and Media, 7:30pm-8:30pm JST (Presentation and Q&A Session)

Participants:

  • Christophe Weber, President and Chief Executive Officer
  • Costa Saroukos, Chief Financial Officer
  • Andy Plump, President, Research & Development and others

 

Document Q1 Q2 
Financial Statements (Tokyo Stock Exchange filling) PDF_file_icon.svg.png PDF_file_icon.svg.png

Quarterly Financial Report

PDF_file_icon.svg.png PDF_file_icon.svg.png
 

Excel version of selected tables from the Quarterly Financial Report

Microsoft_Office_Excel_(2019–present).svg.png Microsoft_Office_Excel_(2019–present).svg.png

Presentation

PDF_file_icon.svg.png PDF_file_icon.svg.png
Webcast

microphone.png

microphone.png

 

Clinical trial summary (updated Oct 27, 2022) pdf2.png

Epidemiology data (updated May 11, 2022) pdf2.png